已发表论文

艾滋病患者马尔尼菲疟原虫继发性伊万氏综合征的存在

 

Authors Wang M, Zhang Z, Yan J, Shi J, Liu S, Wan H

Received 8 January 2021

Accepted for publication 4 March 2021

Published 29 March 2021 Volume 2021:14 Pages 1265—1271

DOI https://doi.org/10.2147/IDR.S300082

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Suresh Antony

Objective: Talaromyces marneffei  (T.M) is a common opportunistic fungus in human immunodeficiency virus (HIV) infection individual. Secondary Evans syndrome in AIDS patients with Talaromyces marneffei  infection has not been reported before. Here, we described cases related to this comorbidity.
Methods: AIDS patients diagnosed with Talaromyces marneffei  infection from 2016 to 2020 at Xixi Hospital of Hangzhou were included in this retrospective study.
Results: Total 76 AIDS patients with T.M infection were enrolled. The most common symptoms were fever and cough (70/76; 55/76, respectively). 53/76 (69.74%) patients got positive results of direct antiglobulin test. 14/76 AIDS-T.M patients combined with secondary Hemophagocytic lymphohistiocytosis (HLH). Five patients were diagnosed with AIDS-T.M associated Evans syndrome. There were severe inflammatory reaction, liver dysfunction, coagulation dysfunction and immunodeficiency status in AIDS-T.M patients with secondary Evans syndrome. All patients received antifungal therapy and three patients received corticosteroids for Evans syndrome treatment. One patient died due to sepsis.
Conclusion: AIDS-T.M patients with secondary Evans syndrome is extremely rare and we need to be alert to the occurrence of secondary Evans syndrome in AIDS-T.M patients. Clinicians should timely start effective antifungal treatments with suspicious T.M infection in AIDS patients.
Keywords: Talaromyces marneffei , Evans syndrome, human immunodeficiency virus, clinical characteristics